Skip to content
Science continues to confirm a role for the gut flora during pregnancy for the general health of mother and baby; one of the most recent studies has now focused on the use of what they call ‘synbiotics’ (the combination of probiotics and prebiotics) to help prevent gestational diabetes.
The findings of the latest study1, led by S. Ahmadi, will be published in the British Journal of Nutrition, and add extra weight to argument that the health of the intestinal flora is a key consideration in pregnancy, now potentially for the prevention of some associated health issues.
Gestational diabetes mellitus (GDM) may affect up to 9% of pregnant women, and results in elevated blood glucose levels. It’s thought that in some individuals, the body is unable to produce enough insulin to cope with the additional demands of pregnancy; risk factors include a family history of diabetes, a personal history of gestational diabetes in previous pregnancies, a body mass index (BMI) of over 30, or being of Asian, Chinese, African-Caribbean or Middle Eastern descent2.
Researchers said that the aim of the latest randomised, double-blind, placebo-controlled trial (see Probiotics Learning Lab for more glossary terms) was “to determine the effects of synbiotic supplementation on markers of insulin metabolism and lipid profiles in GDM patients”. During the trials, seventy patients aged 18-40 years who had been diagnosed with GDM were split into two groups. In the first group some subjects were given a placebo capsule for six weeks, whilst those in the synbiotic group were given a capsule containing L. acidophilus, L. casei and B. bifidum strains, (2×109 colony-forming units/g each) plus 800 mg inulin for 6 weeks. To monitor the effects, two fasting blood samples were collected, one at the beginning of the trial and another at the end of week six.
The results indicated that, compared with the placebo group, the synbiotic group experienced positive and measurable improvements in insulin metabolism and sensitivity, triglyceride levels and VLDL-cholesterol concentrations. In the placebo group, however, no improvements were seen and in fact the readings for many of the subjects showed a marked deterioration since the start of the trial.
“This suggests that synbiotic supplementation may confer advantageous therapeutic potential for patients with gestational diabetes mellitus. ” S. Ahmadi et al (2016)
It is amazing to think that serious health issues such as gestational diabetes may be avoided by simply supplementing with live cultures. It’s not clear which strains of each species of bacteria were used, but the study illustrates the importance of considering gut health in pregnancy, both for the mother’s health and that of the unborn child.
A more recent study reported that the gut microbiome appears to play a role in inflammation-induced gestational diabetes development, with interleukin-6 as a potential contributor. Researchers concluded that women's microbiota could serve as a target for early diagnostics and therapeutic intervention leading to prevention3.
Fellow nutritional therapist, Kathy, recently reported some ground-breaking evidence which challenged our previous understanding that the womb was a sterile environment. A review of recent research into this area suggests that the mother’s resident bacteria may actually pass via the placenta to the unborn baby, and could even play a part in foetal development. Read Kathy's fascinating blog about this over in the Probiotics Learning Lab: 'Do babies come into contact with bacteria in the womb?
For more related articles click on the links below:
Can probiotics help with mastitis and breast health?
Could Lactobacilli probiotics reduce complications in pregnancy? (over in the Probiotics Learning Lab)